Use Calcipotriene/Betamethasone Dipropionate Gel (Dovobet)
For scalp psoriasis, you should use the calcipotriene/betamethasone dipropionate combination gel rather than betamethasone lotion alone. The 2021 Joint AAD-NPF Guidelines give this a Grade A recommendation specifically for scalp psoriasis treatment 1.
Why the Combination is Superior
The combination product is more effective than betamethasone monotherapy for several key reasons:
Greater efficacy: In a 52-week study of 828 patients, 69-74% achieved clear or almost clear skin with the combination versus only 27% with vehicle control 1. The combination was shown to be "slightly more efficacious than betamethasone as a monotherapy" 1.
Better long-term safety profile: No serious adverse events, including striae or hypothalamic-pituitary-adrenal axis suppression, were observed over 52 weeks of treatment with the combination 1. The vitamin D analogue (calcipotriene) helps reduce the adverse effects associated with prolonged corticosteroid use 1.
Sustained remission: After treatment discontinuation, 48% of patients using calcitriol (another vitamin D analogue) remained in remission compared to only 25% using betamethasone alone 1.
Specific Treatment Protocol
Apply once daily for 4-12 weeks to the affected scalp areas 1. The guidelines specifically recommend this duration for scalp psoriasis with Grade A evidence.
Important Caveats
Avoid salicylic acid: Do not use salicylic acid products simultaneously, as the acidic pH will inactivate calcipotriene and reduce effectiveness 1.
Timing with phototherapy: If using UV therapy, apply the combination after phototherapy treatment to avoid inactivation by UVA radiation 1.
Efficacy timeline: Full efficacy may not be apparent until 8 weeks of treatment, not at 4 weeks 1. Set patient expectations accordingly.
The Evidence Hierarchy
The recommendation for combination therapy over monotherapy is supported by multiple high-quality randomized controlled trials and carries the highest level of guideline recommendation (Grade A) 1. While betamethasone alone has anti-inflammatory effects, the addition of calcipotriene provides complementary mechanisms—inhibiting keratinocyte proliferation and enhancing differentiation—that target the underlying pathophysiology of psoriasis more comprehensively 1.
Bottom line: The combination product offers superior clearance rates, better long-term safety, and improved maintenance of remission compared to corticosteroid monotherapy for scalp psoriasis.